| 摘要 |
<p>A transocular preparation containing an oxaspirooctane derivative represented by general formula (I) or a salt thereof as an active ingredient and a pharmaceutically acceptable carrier, wherein R1 represents carbamoyl, etc., R2 represents lower alkoxy, etc., and R3 represents a group of formula (II), etc.</p> |
